Sep 2026· Cell Host and Microbe· Vol 34, pp. 1930-1947.e8· 0 citations· 48 references
Medicine
TL;DR
Findings establish SA as a multifaceted driver of GC and highlight the saSNF2-ZDHHC11 axis as a target to potentiate immunotherapy.
Abstract
First-line treatment for gastric cancer (GC) includes PD-1 blockade with chemotherapy, but resistance challenges treatment success. We identify Streptococcus anginosus (SA) as a tumor-resident oncobacterium driving GC progression and immune evasion. SA is enriched in GC patient tumors and drives tumor growth in mice. SA extracellular vesicles (saEVs) translocate the bacterial chromatin remodeler saSNF2 into host cells. saSNF2 partners with host transcription factor TEAD1-through its ATPase activity and participation in BRG1/BRM-associated factor (BAF) complex assembly-to activate oncogenic transcription. This transkingdom interaction upregulates the palmitoyltransferase ZDHHC11, which stabilizes PD-L1 via palmitoylation to establish an immunosuppressive niche, while amplifying other TEAD1 target genes to fuel tumor progression. saEVs promote tumor growth and limit CD8+ T cell infiltration in vivo. Pharmacological inhibition of ZDHHC11 reverses immune evasion and synergizes with anti-PD-1 checkpoint blockade. These findings establish SA as a multifaceted driver of GC and highlight the saSNF2-ZDHHC11 axis as a target to potentiate immunotherapy.
These findings establish AR phase separation as a fundamental mechanism driving GC pathogenesis and propose co-targeting AR condensates and chromatin remodeling as a translatable therapeutic strategy.
Hua-Huan Liu, Yan-Xin Yao, Xiang-Nan Zhang et al.· Cell Death & Disease· 0 citations
T cell exhaustion within the tumor microenvironment poses a major barrier to effective cancer immunotherapy, yet the epigenetic mechanisms that preserve functional states of tumor-infiltrating T cells remain incompletely understood. Here, using an in vivo CRISPR screen, we identify heterogeneous nuclear ribonucleoprote...
Shi Liu, W. Gao, Meng-Long Hu et al.· Cancer Discovery· 0 citations
It is reported that, in an UVB induced Braf V600E-mutated spontaneous mouse melanoma model, p38α contributes to tumor fitness and anti-tumor immune responses, showing that p38α inhibition sensitizes tumors to anti-PD1.
Paula Granado-Martínez, K. McGrail, Roberto Orsenigo et al.· Nature Communications· 0 citations
Mitophagy serves as a pivotal metabolic-immune hub that drives immune evasion in major skin cancer subtypes including melanoma cutaneous squamous cell carcinoma and basal cell carcinoma. It acts as a core barrier to effective immunotherapy. Mitophagy activates canonical mitophagic pathways such as PINK1 Parkin and BNIP...
Jian Lv, Gui-Jun Liu· Frontiers in Immunology· 0 citations
This work reveals that POSTN + CAFs establish an immunosuppressive TME and are associated with ICB non-response in GC by remodeling lipid metabolism through the ITGB1-PI3K/AKT/mTOR-PPARγ axis, a finding that underscores the therapeutic value of intervening in this specific CAF-macrophage metabolic crosstalk.
Qin Ding, Zi-Teng Li, Rui-Wen Liu et al.· Redox Biology· 0 citations
Overall, it is found that the post-transcriptional regulator HuR facilitates immune evasion in PDAC by constraining T-cell function, identifying HuR blockade as a promising therapeutic strategy in combination with immunotherapies.
Yi-Fei Guo, Jennifer M. Finan, Alexandra Q. Bartlett et al.· Cancer immunology research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.